News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) Abandons Three R&D Areas, Slashes 70+ Jobs



11/8/2013 7:33:12 AM

Bristol-Myers is cutting jobs but others are hiring right now! Check it out! (Isn't it tempting?)

Bristol-Myers Squibb has laid off as many as 20 people in its clinical development/operations group at ZymoGenetics in Seattle as part of a companywide R&D restructuring, Xconomy has learned. New York-based Bristol-Myers acquired ZymoGenetics for about $885 million in October 2010, and pledged a few months later to retain the remaining 275 employees at the Seattle biotech company. Bristol-Myers allowed the local operation keep its landmark headquarters, the former City Light Steam Plant, and its ZymoGenetics identity and brand logo on the sign above the door on Eastlake Avenue East.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Read at Xconomy
Read at BusinessWeek
Read at Pharma Times [Free Reg Req'd]
Read at Pharmalot
Read at Reuters


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES